IL173919A0 - Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias - Google Patents

Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias

Info

Publication number
IL173919A0
IL173919A0 IL173919A IL17391906A IL173919A0 IL 173919 A0 IL173919 A0 IL 173919A0 IL 173919 A IL173919 A IL 173919A IL 17391906 A IL17391906 A IL 17391906A IL 173919 A0 IL173919 A0 IL 173919A0
Authority
IL
Israel
Prior art keywords
phenylcarboxamides
beta
treatment
combination
adrenergic receptor
Prior art date
Application number
IL173919A
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34202398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL173919(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of IL173919A0 publication Critical patent/IL173919A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL173919A 2003-09-08 2006-02-23 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias IL173919A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10341233A DE10341233A1 (en) 2003-09-08 2003-09-08 Composition, useful to treat e.g. atrial fibrillation, atrial flutter and atrial arrhythmia, comprises at least one beta-blocker and at least one compound of a phenylcarboxylic acid amide derivative
PCT/EP2004/009837 WO2005025674A1 (en) 2003-09-08 2004-09-03 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias

Publications (1)

Publication Number Publication Date
IL173919A0 true IL173919A0 (en) 2006-07-05

Family

ID=34202398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL173919A IL173919A0 (en) 2003-09-08 2006-02-23 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias

Country Status (12)

Country Link
EP (1) EP1670551A1 (en)
JP (1) JP2007505036A (en)
AR (1) AR045601A1 (en)
AU (1) AU2004271697A1 (en)
BR (1) BRPI0414203A (en)
CA (1) CA2538009A1 (en)
DE (1) DE10341233A1 (en)
IL (1) IL173919A0 (en)
MX (1) MXPA06002103A (en)
PE (1) PE20050373A1 (en)
TW (1) TW200526580A (en)
WO (1) WO2005025674A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005028862A1 (en) * 2005-06-22 2007-01-11 Sanofi-Aventis Deutschland Gmbh Substituted heterocycles, their use as medicament and pharmaceutical compositions containing them
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
CN105254557A (en) 2009-05-29 2016-01-20 拉夸里亚创药株式会社 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19947457A1 (en) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh New 2'-aminomethyl-biphenyl-2-carboxamide derivatives, are potassium channel blockers especially useful for treating re-entry or supraventricular arrhythmia or atrial fibrillation or flutter
DE10059418A1 (en) * 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10060807A1 (en) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituted nitrogen-containing bisaryl compounds, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10121003A1 (en) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilic acid amides, processes for their preparation, their use as medicaments and pharmaceutical preparations containing them
DE10128331A1 (en) * 2001-06-12 2002-12-19 Aventis Pharma Gmbh New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter

Also Published As

Publication number Publication date
AU2004271697A1 (en) 2005-03-24
BRPI0414203A (en) 2006-10-31
EP1670551A1 (en) 2006-06-21
CA2538009A1 (en) 2005-03-24
WO2005025674A1 (en) 2005-03-24
JP2007505036A (en) 2007-03-08
AR045601A1 (en) 2005-11-02
DE10341233A1 (en) 2005-03-24
MXPA06002103A (en) 2006-05-31
PE20050373A1 (en) 2005-07-05
TW200526580A (en) 2005-08-16

Similar Documents

Publication Publication Date Title
IL159347A0 (en) Arylamines for the treatment of conditions associated with gsk-3
HK1091732A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
ZA200607956B (en) Gossypol co-crystals and the use thereof
EP1456910A4 (en) Invasive therapeutic probe
EP1596746A4 (en) Cardiac ablation devices
ZA200710111B (en) New oxabispidine compounds for the treatment of cardiac arrhythmias
EP1719792A4 (en) Crosslinked polyimide compound and use thereof
IL173919A0 (en) Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
PL375561A1 (en) Therapeutic use
ZA200610297B (en) Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
EP1732599A4 (en) Use of emmprin antagonists for the treatment of diseases associated with excessive angiogenesis
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
IL164951A0 (en) The treatment of pain with lfendropil
GR1004664B (en) The charakteristics and advantages of our invention are illustrated by the following description, methods and results of our research, attached figures and supporting references
GB0316502D0 (en) The structure of exotic panties
AU2002356679A8 (en) Clusianon isomers and use thereof
TW503735U (en) ECG device with sphygmomanometer functions
EP1549664A4 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
GB0206091D0 (en) New medical use
ITPD20020100A1 (en) TROCAR FOR ENGRAVINGS WITH COVERING AND DISCOVERY MECHANISM OF THE SCALPEL
TW560271U (en) Structure of case-type umbrella
GB0225190D0 (en) Telescopic measure/telescopic staff
TW592048U (en) Improved hat and pad of the same
HU0402409D0 (en) Protective device especially against sport-injury of the part between foot and shank